Endogenous opiates (endorphins) mediate a variety of motivational and behavioral states. We examined the possible contributions of endorphins to the exploratory behavior of mice. Naloxone, ablocker of opiate receptors, depressed hole board exploratory activity and entry into a novel environment. It also reduced responding for sensory stimulation. Finally, a direct correlation was demonstrated between exploratory behavior on the one hand, and enkephalininduced behavioral activation on the other. 
therefore be involved in exploration and we accordingly have examined the effects of drugs affecting narcotic receptors upon exploration in the mouse. The four tasks used to assess opiate involvement were hole board exploration (nose poking), operant responding for sensory reinforcement, entry into a novel environment, and psychomotor stimulation.
GENERAL METHODS Subjects
A subject pool of 99 adult male Swiss-Webster albino mice (Charles River, Portage, Mich.), each 30 to 40 g, was maintained on ad libiturn food and water, For Experiments 1, 3, and 4, subjects were maintained on day/night cycles of 12 hr and group housed four to eight mice per cage. For Experiment 2, subjects were maintained in constant dim illumination and were housed individually.
Apparatus
The hole board apparatus (Experiment l) was modified from the design of File and Wardill (1975) and consisted of an 8.5 x 29.5 x 15 cm clear Plexiglas box with a suspended black Plexiglas floor containing two beveled 1-cm-diameter holes. Head entry into either hole allowed viewing of a diffusely lit field. The apparatus floor was washed thoroughly between tests,
The apparatus for testing sensory reinforcement (Experiment 2) was a standard operant chamber (Scientific Prototype A-100:19 x 20 x 23.5 cm) with a centrally located lever with an operating requirement of 6 g. Each bar press produced a 0.5-sec activation of a 6-W 125-V chamber light accompanied by an audible relay click.
The apparatus for testing exploration of a novel environment (Experiment 3) consists of a box with two interconnected and highly distinctive chambers. The first chamber was white and cubical (18 cm/side) and had a grid floor. The second was black and prismatic, with a floor design of an equilateral right triangle (18 x 18 x 25.4 in.) and a height of 18 cm. The black chamber had a mesh rather than a grid floor.
Exploratory activity and behavioral activation by an enkephalin analog (Experiment 4) were measured by four field sensitive activity monitors (Stoelting, Chicago) calibrated to within 5% of each other. The testing cages (51 x 41 x 22 cm polypropylene cages; Scientific Products series 70) were placed directly on the platforms with a fresh bedding of pine chips in each cage. Additional details of this apparatus have been published elsewhere (Katz et al., 1978) .
Drugs
For Experiments 1 through 3, N-allylnoroxymorphone-HC1 (naloxone-HC1; Narcan; Endo Laboratories, Inc., N.Y.) was injected in a sterile vehicle solution of 0.9% sodium chloride. All injections used a standard 0.4 mg/ml solution and injection volumes of 5, 10, and 20 ml/kg to deliver 2, 4, and 8 mg/kg. All injections were administered intraperitoneally, 10 to 15 min prior to the start of testing. Initial testing of 50 mice (25 experimental, 25 control) revealed that no motor impairment was induced by any drug dose as measured by a grid tilted perpendicular to the floor. Fewer than 10% of any experimental or control groups fell from the grid after it had been tilted.
For Experiment 4, D-Ala2-Leu-enkephalinamide (No. 8619, Peninsula Inc., San Carlos, Calif.) was injected, 25 /xg/mouse, through a permanently indwelling stainless-steel intraventricular cannula that had been previously implanted stereotaxically under sodium pentobarbital anesthesia. A vehicle solution of 10 ~1 of Ringer-Locke solution was infused over 30 sec. The injection procedure, although employing a relatively large volume, has previously been shown to produce stable running (Katz et al., 1978) . Additional details of cannula construction and injection procedure have been published elsewhere (Katz et al., 1978) .
Methods of Procedure
(1) Hole board. Subjects (n = 58) were injected as described with drug or vehicle. Testing involved placing subjects individually within the hole board apparatus and recording entries into either hole for two consecutive 5-min periods. Only complete entries of the nose into a hole were recorded.
(2) Sensory reinforcement. Mice (n = 7) maintained undisturbed for at least 7 days in a dimly lit and quiet environment received 60 min of initial operant shaping to bar press for a light and relay click reinforcement. They were then administered drug or vehicle injections as described and tested for responding. Sessions of 90 rain each were spaced at least 72 hr apart, and each subject was tested twice at each dose level. An ABAB design was used with drug and vehicle sessions following each other. This particular housing and testing regimen has, in our hands, produced stable responding over repeated testing. Baseline stability is an important consideration when repeated measures designs are employed.
(3) Novel environment. Subjects (n =9) were injected as described.
Testing involved placing subjects into the white compartment of the test apparatus and recording (a) latency to enter the second compartment and (b) total crossings between compartments in 5 min.
(4) Exploratory behavior---enkephalin running. Subjects (n = 25) were exposed to the cages and allowed to explore until 20 rain free from any movement, as registered upon the sensors. A standard dose of enkephalin analog was then injected as described, using a Hamilton microsyringe and manual infusion procedure. The dose of enkephalin had previously been shown to induce a high stable period of sterotyped running activity (Katz et al., 1978) . Recording continued until 20 rain without movement. All testing began between 9:00 and 10:00 AM. Three measures of activity (total, average, and maximal activity) were recorded and compared during exploration and drug induced stimulation within subjects, using ten-min recording intervals. Total activity represented the cumulative sum of activity prior to quiescence. Mean activity was total divided by the number of 10-min blocks, and peak was the largest 10-min block occurring during exploration and drug periods for a given subject. Statistical analysis, t-Tests, analysis of variance, and bivariate correlation procedures were used for all comparisons (Bruning and Kintz, 1977) .
EXPERIMENT 1
The purpose of Experiment 1 was to examine the effects of narcotic blockade on hole board exploration. This form of exploratory activity is common to rodents and is susceptible to both environmental and pharmacological manipulation (Boissier and Simon, 1962; File and Wardill, 1975; Makanjuola et al., 1975; Minck et al., 1974; Nakama et al., 1972) .
Results
Naloxone produced a graded and dose related decrease in hole board exploration (Fig. 1) . Inspection of initial scores indicated a high degree of correlation between 0-to 5-rain and 6-to 10-rain scores within subjects (r = 0.44). Since this correlation is significant (Fisher Z transformation = 3.4; P < 0.01) scores were combined to simplify analysis. ANOVA using a randomized design indicated a significant drug effect (F(3, 55) = 14. 0.001). Individual comparisons (Dunnetts test) indicated significant effects for 4 and 8 mg/kg (P < 0.05 and P < 0.01, respectively, in comparison with 0 mg/kg).
Discussion
The results of Experiment 1 suggest the possible involvement of an opiate receptor in hole board exploration. It might be inferred that some endogenous receptor ligand may therefore also be behaviorally involved.
Experiment 2 examined the effects of opiate receptor blockade upon an operant analog of exploration, sensory reinforcement. In the sensory reinforcement paradigm operant responding upon a manipulandum produces a discrete and response contingent alteration in the experimental chamber. In the present case, this consisted of an increase in both illumination and ambient noise.
EXPERIMENT 2
In Experiment 2, the same dosage range of naloxone as used in Experiment I was used to affect responding for sensory reinforcement in the apparatus previously described. Experiment 1 suggests that mice will respond less frequently to produce environmental novelty, just as they previously made fewer responses to view a novel visual environment.
Results
Responding for sensory stimulation was significantly reduced by naloxone (F(13, 57) = 23.6; P < 0.001). All three drug groups were significantly lower than the control group (P < 0.05 in each case by Dunnetts test). Figure 2 indicated both a monotonic dose-response relationship and recovery between drug sessions.
Discussion
Narcotic blockade interfered with operant responding for environmental novelty as well as with hole board exploration. Both actions are consistent with opiate involvement in the motivating properties of environmental novelty. A final test of this involvement was carried out in Experiment 3.
EXPERIMENT 3
Experiment 3 examined the effects of a dose of naloxone (8 mg/kg) which had been shown to be effective in the two previous experiments and used a third exploratory situation. Subjects were placed in a box which allowed a choice of two distinctly different environments. Under conditions of high exploratory motivation, it might be predicted that more crossing between the two compartments would occur. On the other hand, animals showing lower exploratory behavior should spend less time crossing from one compartment to the other.
Results
Two measures of exploratory activity were taken (latency to enter the second compartment, total crossings between compartments). Naloxone treated subjects showed a lowering of responding on both measures, but only one (total crossing) was significant. Both findings are presented in > 0.05) and that total entries (i.e., crossing between compartments) were lower under drug treatment (t = 4.9; P < 0.01).
Discussion
Experiment 3, as the previous two experiments, showed a reduction in responding for novelty under conditions of narcotic blockade. Experiments 1, 2, and 3 are all consistent in their findings. Experiment 4 attempted to examine a converse interaction, whether activation by an agonist of opiate receptors would be related to exploratory activity. Opiates are known to increase exploration (see above). However, the activation caused in mice by opiates is highly atypical and cannot be classified as exploratory (Kreuger et al., 1941; Brase et al., 1977; Katz et al., 1978) .
EXPERIMENT 4
Since a direct increase in motor stimulation after opiates in mice may represent behaviors extrinsic to normal exploration, we used an indirect assessment of an exploration--motor stimulation relationship. In this procedure, subjects were first allowed to explore a novel environment until they ceased moving and then were injected centrally with a standard dose of long acting opiate agonist. Any correlation between initial exploration and later opiate activation could be taken to indicate some common mechanism (presumably some common receptor for the opiate agonist).
Results
Figures 4, 5, and 6, respectively, show total, maximal, and average activity for a group of 25 mice, both during exploration and during drug activation. The three figures show a monotonic relationship between these variables across subjects, with correlations of + 0.71, + 0.78, and + 0.84. This relationship is further confirmed by visual inspection. In all cases a significant relationship exists between variables (t = 4.81, 5.9, 7.5, respectively, df = 23 by Fishers transformation, P < 0.0001). Histology for cannula placement consisted of injecting a volume of commercially prepared black ink equivalent to the original injection volume. Ten minutes after injection subjects were decapitated under ether anesthesia and their brains were dissected and examined for the presence of ink along the ventricular surface. All subjects showed ink through the entirety of their ventricles with this procedure. The majority of subjects showed no or only limited signs of injection trauma.
GENERAL DISCUSSION
The present results using naloxone and an enkephalin analog suggest opiate involvement in exploration. Clearly the specificity of the present manipulations with respect to the established pharmacology of opiate Fie. 4. Relationship of total exploratory activity (x axis) and activity after activation by an enkephalin analog (y axis). Individual scores are presented. drugs should be examined critically. For example, do the manipulations of the present study reflect established practice and normal dosage ranges? The major effects reported with naloxone occurred at 8 mg/kg. In fact this dose represents a moderate to high dosage range and may involve some nonspecific effects. A careful examination of Figs. 1 and 2 , however, indicates that doses as low as 2 mg/kg produce behavioral reductions of 40 to 60%. Thus, effects were also seen at low and fairly specific drug doses. While nonspecific effects cannot be entirely excluded it is clear that a low dose of antagonist affected two tasks with differing sensory and motor requirements. Further testing with other agonists and antagonists is currently planned, and this should additionally address the question of specificity.
It might also be argued that opiate reversal of naloxone effects would add to the specificity of our results. We have previously argued that in our experience opiates produce atypical activation and unique sensory changes at least in mice (Katz et al., 1978) . This renders direct behavioral assessment of agonist-antagonist interactions difficult, although it should be noted that other reports using rats have demonstrated opiate effects predicted by the present hypothesis (see above). Also, our results with an enkephalin analog, insofar as they reflect a more general responsivity to naturally occuring ligands, at least indirectly suggest opiate agonists produce expected activating effects. It is difficult to test naturally occurring enkephalins because of their short duration of action (e.g., Belluzzi et al., 1977) . yowever, analogs appear to produce effects similar to those of the natural compounds (e.g., Akil, 1977) and may represent reasonable substitutes, at least until some means of prolonging the action of biological compounds is possible.
The present findings suggest the involvement in exploratory activity of some endogenous compound which occupies the opiate receptor. Three possible interpretations may be advanced to explain these findings. It might be argued that some sensory alteration was produced by the drugs, or that some motor incapacity was produced, or finally, that some motivational change was responsible.
By the first, or sensory explanation, naloxone would presumably have to interfere with the sensory encoding of stimulus novelty, and the enkephalin analog would have to have an opposite effect. Such an explanation is unlikely, because naloxone increases rather than decreases sensory responsivity, e.g., in responding to a painful situation (Berntson and Walker, 1977; Frederickson et al., 1977) while morphine and enkephalins conversely produce a decrease rather than an increase in sensory responsivity (analgesia; Akil, 1976; Belluzzi et al., 1976) . If anything, other experiments therefore argue for effects opposite to those obtained, at least on purely sensory grounds.
Objections might also be made to a purely locomotor interpretation of these findings. On the one hand, naloxone was initially tested for its ataxia producing capacity and all dosages were found to have minimal effects upon responding to a tilted grid. Naloxone also induces a hyperresponsivity to pain characterized by greater than normal movement (Frederickson et al., 1977; Belluzzi and Stein, 1977) . Thus, an inability to move is probably not involved in the present results.
Both naloxone and enkephalins are known to have a variety of effects upon the motivation for reward and punishment, however (see above). It might therefore be asked if a motivational interpretation of these results is possible. Clearly, exploratory activity is mediated by motivating factors (Berlyne, 1960; Christopher and Butter, 1968) and novel stimuli do appear to have rewarding properties. One interpretation of our results might be that naloxone interferes with the rewarding properties of novel stimuli. Under such an interpretation, stimuli would be less sought after because they lose their motivating (i.e., activating and reinforcing) properties and therefore cease to reinforce exploratory behavior. Since opiates are involved with reward (Stein and Belluzzi, 1978) and since reward is one factor in exploratory behavior, this interpretation is possible.
